About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...

Sarepta recently filed for approval to extend the label for Elevidys to include all ambulatory DMD patients, despite missing its primary objective in a phase 3 trial. Image. Phil Taylor.

FDA probing deaths with DMD gene therapy Elevidys. The FDA has launched a formal investigation into two liver failure-related deaths in patients treated with Duchenne gene therapy Elevidys.